FineMark National Bank & Trust’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

FineMark National Bank & Trust’s Portfolio WX Stock Details WX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-957	Closed	-$41K	–	1557
2015 Q3	$41K	Hold	957	–	–	0.01%	678
2015 Q2	$40K	Hold	957	–	–	0.01%	710
2015 Q1	$37K	Buy	957 +423	+79%	+$16.3K	0.01%	742
2014 Q4	$18K	Hold	534	–	–	﹤0.01%	934
2014 Q3	$19K	Hold	534	–	–	﹤0.01%	904
2014 Q2	$18K	Hold	534	–	–	﹤0.01%	929
2014 Q1	$20K	Hold	534	–	–	﹤0.01%	896
2013 Q4	$20K	Buy	+534	New	+$16.9K	﹤0.01%	846

Other funds holding WX

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

CCS

Crosspoint Capital Strategies Orinda, California $50.4M AUM 15.37% 1-Year Est. Return

FineMark National Bank & Trust's WX Position: Q4 2015 in Review

FineMark National Bank & Trust sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q4 2015, closing a stake of 957 shares — an estimated $41K sold.

FineMark National Bank & Trust first reported a position in WX in Q4 2013 and held it in 8 quarters. The position peaked at $41K in Q3 2015. 2 funds tracked by Wall St. Rank hold WX as of Q4 2015.

FineMark National Bank & Trust reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q4 2015 after selling out during the quarter.
FineMark National Bank & Trust sold 957 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q4 2015, an estimated $41K.
FineMark National Bank & Trust first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q4 2013 and held it in 8 quarters.
FineMark National Bank & Trust's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $41K in Q3 2015.
2 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q4 2015.

Based on FineMark National Bank & Trust's 13F filing for Q4 2015, filed 9 Feb 2016.